Search
Close this search box.

Day: September 3, 2025

Synopsis and Telnyx Partner to Deliver Scalable Communications and Voice AI Across MENA

AUSTIN, Sept. 03, 2025 (GLOBE NEWSWIRE) — Telnyx, the full-stack conversational AI platform powering global communications, is proud to announce a new partnership with Synopsis, a leading technology distributor in the Middle East and Africa (MEA). This collaboration will unlock scalable, high-performance voice and connectivity solutions tailored to the region’s rapidly growing digital market. As one of […]

READ MORE ...

BHVN DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Biohaven Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 12 Deadline in Securities Class Action – BHVN

NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Biohaven Ltd. (NYSE: BHVN) between March 24, 2023 and May 14, 2025, both dates inclusive (the “Class Period”), of the important September 12, 2025 lead plaintiff deadline. SO WHAT: If you purchased Biohaven securities during […]

READ MORE ...

CNC FINAL DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Centene Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important September 8 Deadline in Securities Class Action – CNC

NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Centene Corporation (NYSE: CNC) between December 12, 2024 and June 30, 2025, both dates inclusive (the “Class Period”), of the important September 8, 2025 lead plaintiff deadline. SO WHAT: If you purchased Centene securities during […]

READ MORE ...

ANRO DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Alto Neuroscience, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ANRO

NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Alto Neuroscience, Inc. (NYSE: ANRO): (i) pursuant and/or traceable to Alto’s initial public offering conducted on or about February 2, 2024 (the “IPO”); and/or (ii) securities between February 2, 2024 and October […]

READ MORE ...